Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation

Aims Survivors of allogeneic haematopoietic stem-cell transplantation (allo-HSCT) are at higher risk of cardiovascular disease. We aimed to describe right ventricular (RV) systolic function and risk factors for RV dysfunction in long-term survivors of allo-HSCT performed in their youth.Methods and r...

Full description

Saved in:
Bibliographic Details
Main Authors: Lars Gullestad, Anette Borger Kvaslerud, Svend Aakhus, Jan Otto Beitnes, Richard John Massey, Phoi Phoi Diep, Marta Maria Burman, Lorentz Brinch, Ellen Ruud
Format: Article
Language:English
Published: BMJ Publishing Group 2021-12-01
Series:Open Heart
Online Access:https://openheart.bmj.com/content/8/2/e001768.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846170616625889280
author Lars Gullestad
Anette Borger Kvaslerud
Svend Aakhus
Jan Otto Beitnes
Richard John Massey
Phoi Phoi Diep
Marta Maria Burman
Lorentz Brinch
Ellen Ruud
author_facet Lars Gullestad
Anette Borger Kvaslerud
Svend Aakhus
Jan Otto Beitnes
Richard John Massey
Phoi Phoi Diep
Marta Maria Burman
Lorentz Brinch
Ellen Ruud
author_sort Lars Gullestad
collection DOAJ
description Aims Survivors of allogeneic haematopoietic stem-cell transplantation (allo-HSCT) are at higher risk of cardiovascular disease. We aimed to describe right ventricular (RV) systolic function and risk factors for RV dysfunction in long-term survivors of allo-HSCT performed in their youth.Methods and results This cohort included 103 survivors (53% female), aged (mean±SD) 17.6±9.5 years at allo-HSCT, with a follow-up time of 17.2±5.5 years. Anthracyclines were used as first-line therapy for 44.7% of the survivors. The RV was evaluated with echocardiography, and found survivors to have reduced RV function in comparison to a group of healthy control subjects: Tricuspid annular plane systolic excursion, (TAPSE, 20.8±3.7 mm vs 24.6±3.8 mm, p<0.001), RV peak systolic velocity (RV-s’, 11.2±2.3 cm/s vs 12.3±2.3 cm/s, p=0.001), fractional area change (FAC, 41.0±5.2% vs 42.2±5.1%, p=0.047) and RV free-wall strain (RVFWS, −27.1±4.2% vs −28.5±3.3%, p=0.043). RV systolic dysfunction (RVSD) was diagnosed in 14 (13.6%), and was strongly associated with progressive left ventricular systolic dysfunction (LVSD). High dosages of anthracyclines were associated with greater reductions in RV and LV function. Multivariable linear regressions confirmed global longitudinal strain to be a significant independent predictor for reduced RV function.Conclusion Impaired RV function was found in long-term survivors of allo-HSCT who were treated in their youth. This was associated with progressive left ventricle dysfunction, and pretransplant therapies with anthracyclines. The occurrence of RVSD was less frequent and was milder than coexisting LVSD in this cohort.
format Article
id doaj-art-a86a448a9c6542acad83d6b6111285ae
institution Kabale University
issn 2053-3624
language English
publishDate 2021-12-01
publisher BMJ Publishing Group
record_format Article
series Open Heart
spelling doaj-art-a86a448a9c6542acad83d6b6111285ae2024-11-11T14:15:07ZengBMJ Publishing GroupOpen Heart2053-36242021-12-018210.1136/openhrt-2021-001768Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantationLars Gullestad0Anette Borger Kvaslerud1Svend Aakhus2Jan Otto Beitnes3Richard John Massey4Phoi Phoi Diep5Marta Maria Burman6Lorentz Brinch7Ellen Ruud8Center for Heart Failure Research, Oslo University Hospital, Oslo, NorwayFaculty of Medicine, Institute for Clinical Medicine, University of Oslo, Oslo, NorwayDepartment of Circulation and Medical Imaging, Norges teknisk-naturvitenskapelige universitet, Trondheim, NorwayCardiology, Oslo University Hospital, Oslo, NorwayDepartment of Cardiology, Oslo universitetssykehus Hjerte- lunge- og karklinikken, Oslo, NorwayInstitute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, NorwayInstitute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, NorwayHematology, Oslo University Hospital, Oslo, NorwayInstitute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, NorwayAims Survivors of allogeneic haematopoietic stem-cell transplantation (allo-HSCT) are at higher risk of cardiovascular disease. We aimed to describe right ventricular (RV) systolic function and risk factors for RV dysfunction in long-term survivors of allo-HSCT performed in their youth.Methods and results This cohort included 103 survivors (53% female), aged (mean±SD) 17.6±9.5 years at allo-HSCT, with a follow-up time of 17.2±5.5 years. Anthracyclines were used as first-line therapy for 44.7% of the survivors. The RV was evaluated with echocardiography, and found survivors to have reduced RV function in comparison to a group of healthy control subjects: Tricuspid annular plane systolic excursion, (TAPSE, 20.8±3.7 mm vs 24.6±3.8 mm, p<0.001), RV peak systolic velocity (RV-s’, 11.2±2.3 cm/s vs 12.3±2.3 cm/s, p=0.001), fractional area change (FAC, 41.0±5.2% vs 42.2±5.1%, p=0.047) and RV free-wall strain (RVFWS, −27.1±4.2% vs −28.5±3.3%, p=0.043). RV systolic dysfunction (RVSD) was diagnosed in 14 (13.6%), and was strongly associated with progressive left ventricular systolic dysfunction (LVSD). High dosages of anthracyclines were associated with greater reductions in RV and LV function. Multivariable linear regressions confirmed global longitudinal strain to be a significant independent predictor for reduced RV function.Conclusion Impaired RV function was found in long-term survivors of allo-HSCT who were treated in their youth. This was associated with progressive left ventricle dysfunction, and pretransplant therapies with anthracyclines. The occurrence of RVSD was less frequent and was milder than coexisting LVSD in this cohort.https://openheart.bmj.com/content/8/2/e001768.full
spellingShingle Lars Gullestad
Anette Borger Kvaslerud
Svend Aakhus
Jan Otto Beitnes
Richard John Massey
Phoi Phoi Diep
Marta Maria Burman
Lorentz Brinch
Ellen Ruud
Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation
Open Heart
title Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation
title_full Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation
title_fullStr Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation
title_full_unstemmed Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation
title_short Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation
title_sort impaired right ventricular function in long term survivors of allogeneic haematopoietic stem cell transplantation
url https://openheart.bmj.com/content/8/2/e001768.full
work_keys_str_mv AT larsgullestad impairedrightventricularfunctioninlongtermsurvivorsofallogeneichaematopoieticstemcelltransplantation
AT anetteborgerkvaslerud impairedrightventricularfunctioninlongtermsurvivorsofallogeneichaematopoieticstemcelltransplantation
AT svendaakhus impairedrightventricularfunctioninlongtermsurvivorsofallogeneichaematopoieticstemcelltransplantation
AT janottobeitnes impairedrightventricularfunctioninlongtermsurvivorsofallogeneichaematopoieticstemcelltransplantation
AT richardjohnmassey impairedrightventricularfunctioninlongtermsurvivorsofallogeneichaematopoieticstemcelltransplantation
AT phoiphoidiep impairedrightventricularfunctioninlongtermsurvivorsofallogeneichaematopoieticstemcelltransplantation
AT martamariaburman impairedrightventricularfunctioninlongtermsurvivorsofallogeneichaematopoieticstemcelltransplantation
AT lorentzbrinch impairedrightventricularfunctioninlongtermsurvivorsofallogeneichaematopoieticstemcelltransplantation
AT ellenruud impairedrightventricularfunctioninlongtermsurvivorsofallogeneichaematopoieticstemcelltransplantation